Amphastar Pharma Stock Price (NASDAQ:AMPH)

Add to My Stocks
$15.77 $0.33 (2.05%) AMPH stock closing price Jun 22, 2018 (Closing)
Prev Close* : $16.1
Market Cap:
$735.1M
Day Low: $15.76
52 Week Low: $14.40
Open: $16.15
Volume: -
Day High: $16.16
52 Week High: $20.45
Dividend:
0.00

Latest Stock Market News

Latest Articles

Amphastar Pharma News - From Partners

New Strong Sell Stocks for May 29th   by Zacks on May 29, 2018
New Strong Sell Stocks for May 15th   by Zacks on May 15, 2018

AMPH Stockcharts

View AMPH PE ratio, PS ratio stocks charts and compare with peers.
AMPH Chart
Note: Compare Amphastar Pharma stock price history with the index and industry peers.

Amphastar Pharma Valuation

PE ratio
(price earnings ratio)
-999.0000
PS ratio (
price to sales ratio
)
3.03
PB ratio (
price to book ratio
)
2.22

Amphastar Pharma Returns

ROE
(return on equity)
-1%

Amphastar Pharma Financial Ratios

Asset Turnover
0.52
Receivables Turnover
7.5
Debt to Equity
0.14
Dividend Yield
0%

AMPH Industry Peers

Company Price Change (%)
Bactolac Pharma (BTCA)1200000 (0%)
Ventrus Biosciences (ASMB)44.181.53 (3.35%)
Teligent (TLGT)3.880.09 (2.37%)
Halozyme Therapeutics (HALO)18.090.5 (2.69%)
Sanofi (SNY)400.97 (2.49%)
Novartis (NVS)75.061.08 (1.46%)
Mannkind (MNKD)2.010.05 (2.55%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
Aquinox Pharma (AQXP)15.510.79 (5.37%)
Teligent (TLGT)3.880.09 (2.37%)
Akorn (AKRX)16.030.27 (1.71%)
Corium (CORI)8.90.07 (0.79%)
Allergan (AGN)173.420.93 (0.54%)
Progenics Pharma (PGNX)8.490.02 (0.24%)
Top gainers from Medical-Generic Drugs industry
* As of Jun 23, 2018
CompanyPriceChange (%)
Supernus Pharma (SUPN)57.051.3 (2.23%)
Adamas Pharma (ADMS)25.210.29 (1.14%)
Mallinckrodt (MNK)19.270.17 (0.87%)
Mylan (MYL)38.310.32 (0.83%)
AxoGen (AXGN)51.350.4 (0.77%)
Dr. Reddy's Laboratories (RDY)34.070.18 (0.53%)
Teva Pharmaceutical (TEVA)23.990.02 (0.08%)
Top losers from Medical-Generic Drugs industry
* As of Jun 23, 2018

Amphastar Pharmaceuticals Inc Stock News - Partner Headlines

Weekly CEO Buys Highlight   on May 21, 2018
America’s War on Drugs   on Mar 07, 2017

Amphastar Pharma Financial Statements

income statement20172016201520142013
Net Sales or Revenues240.17M255.16M251.51M210.46M229.68M
Net Income4.5M10.53M-2.78M-10.69M11.86M
Total Operating Expense91.68M88.48M84.24M69.23M69.45M
View Amphastar Pharma income statement
balance sheet20172016201520142013
Total Assets454.66M427.73M390.13M389.37M338.74M
Total Liabilities117.33M98.48M94.62M107.51M87.2M
Shareholders Equity337.32M329.25M295.51M281.86M251.54M
View Amphastar Pharma balance sheet
cash flow statement20172016201520142013
Net Increase (Decrease) in Assets Liabilities---5.13M15.61M-3.23M
Net Cash from (used by) Operating Activities39.2M38.56M10.68M21.05M31.04M
Increase (Decrease) in Prop Plant And Equipment-35.09M-21.38M-15.99M-20.49M-18.3M
View Amphastar Pharma cash flow statement

Amphastar Pharma Stock Message Board

An investor needs to spend $15.77 to buy AMPH stock, as the closing Amphastar Pharma stock price is $15.77. Looking at Amphastar Pharma market capitalization, which currently stands at $735.1M, we can say that AMPH stock is a Small Cap stock. Amphastar Pharma valuation can be guaged using various valuation metrics like the price to earnings ratio.

For recognizing and analyzing the real performance of Amphastar Pharma stock, it is a standard practise to adjust historical stock prices to remove gaps caused by stock splits, dividends and distributions. 995,805 AMPH shares were traded yesterday, and Amphastar Pharma stock chart shows that the AMPH stock quote hit a day high of $16.16 and day low of $15.76. A dividend is a cash payment made from a company's earnings and is distributed among shareholders. Amphastar Pharma does not pay dividends. Amphastar Pharma stock price history has details about historical stock quotes, P/E ratios and price to sales ratios.